Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORPE: Fortelizin vs Alteplase in Massive Pulmonary Embolism
NCT04688320Phase 3Completed
- Sponsor
- SuperGen, Inc.
- Start
- Dec 2020
- Primary completion
- Jul 2023
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of staphylokinase in pulmonary embolism (PE), sponsored by SuperGen, Inc.. Started Dec 2020; status: completed.
02
Drugs
staphylokinase
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04688320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688320.